Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gulliver

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Journal of Cutaneous Medicine and Surgery|July 13, 2016
Psoriasis Patients Treated With Biologics and Methotrexate Have a Reduced Rate of Myocardial Infarction: A Collaborative Analysis Using International CohortsWayne P Gulliver, Heather M Young, Hervé Bachelez, et al.
The American Journal of Pathology|February 1, 1992
Human papillomavirus 16 DNA immortalizes two types of normal human epithelial cells of the uterine cervixK Tsutsumi, N Belaguli, S Qi, et al.
Journal of Cutaneous Medicine and Surgery|May 9, 2015
Long-term Management of Moderate to Severe Plaque Psoriasis Patients With Etanercept: A Case SeriesMarc Bourcier, Kim Alexander Papp, Wayne P Gulliver, et al.
The British Journal of Dermatology|February 26, 2018
Effectiveness of systemic treatments for pyoderma gangrenosum: a systematic review of observational studies and clinical trialsA C R Partridge, J W Bai, C F Rosen, et al.
Journal of Cutaneous Medicine and Surgery|November 23, 2018
Comparison of Management Guidelines for Moderate-to-Severe Plaque Psoriasis: A Review of Phototherapy, Systemic Therapies, and Biologic AgentsArvin Ighani, Arun C R Partridge, Neil H Shear, et al.
Journal of the American Academy of Dermatology|November 27, 2002
A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasisGerald G Krueger, Kim A Papp, Dow B Stough, et al.
Journal of Cutaneous Medicine and Surgery|May 22, 2016
Do Biologics Protect Patients With Psoriasis From Myocardial Infarction? A Retrospective CohortWayne P Gulliver, Shane Randell, Susanne Gulliver, et al.
The Journal of Dermatological Treatment|June 19, 2004
Long-term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitisT A Luger, M Lahfa, R Fölster-Holst, et al.
Journal of Psoriasis and Psoriatic Arthritis|September 19, 2024
Development of Psoriasis Assessment Tools Among Patients in the CorEvitas Psoriasis RegistryWayne P Gulliver, Kyoungah See, Baojin Zhu, et al.
Journal of Cutaneous Medicine and Surgery|March 17, 2015
The Relationship Between Dermatologist- and Patient-Reported Acne Severity Measures and Treatment RecommendationsJerry Tan, Marc P Frey, Sanja Knezevic, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Journal of Cutaneous Medicine and Surgery|July 13, 2016
Psoriasis Patients Treated With Biologics and Methotrexate Have a Reduced Rate of Myocardial Infarction: A Collaborative Analysis Using International CohortsWayne P Gulliver, Heather M Young, Hervé Bachelez, et al.
The American Journal of Pathology|February 1, 1992
Human papillomavirus 16 DNA immortalizes two types of normal human epithelial cells of the uterine cervixK Tsutsumi, N Belaguli, S Qi, et al.
Journal of Cutaneous Medicine and Surgery|May 9, 2015
Long-term Management of Moderate to Severe Plaque Psoriasis Patients With Etanercept: A Case SeriesMarc Bourcier, Kim Alexander Papp, Wayne P Gulliver, et al.
The British Journal of Dermatology|February 26, 2018
Effectiveness of systemic treatments for pyoderma gangrenosum: a systematic review of observational studies and clinical trialsA C R Partridge, J W Bai, C F Rosen, et al.
Journal of Cutaneous Medicine and Surgery|November 23, 2018
Comparison of Management Guidelines for Moderate-to-Severe Plaque Psoriasis: A Review of Phototherapy, Systemic Therapies, and Biologic AgentsArvin Ighani, Arun C R Partridge, Neil H Shear, et al.
Journal of the American Academy of Dermatology|November 27, 2002
A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasisGerald G Krueger, Kim A Papp, Dow B Stough, et al.
Journal of Cutaneous Medicine and Surgery|May 22, 2016
Do Biologics Protect Patients With Psoriasis From Myocardial Infarction? A Retrospective CohortWayne P Gulliver, Shane Randell, Susanne Gulliver, et al.
The Journal of Dermatological Treatment|June 19, 2004
Long-term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitisT A Luger, M Lahfa, R Fölster-Holst, et al.
Journal of Psoriasis and Psoriatic Arthritis|September 19, 2024
Development of Psoriasis Assessment Tools Among Patients in the CorEvitas Psoriasis RegistryWayne P Gulliver, Kyoungah See, Baojin Zhu, et al.
Journal of Cutaneous Medicine and Surgery|March 17, 2015
The Relationship Between Dermatologist- and Patient-Reported Acne Severity Measures and Treatment RecommendationsJerry Tan, Marc P Frey, Sanja Knezevic, et al.
Pageof 5